Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cyclerion Therapeutics (CYCN) Cash from Investing Activities (2019 - 2023)

Cyclerion Therapeutics (CYCN) has 4 years of Cash from Investing Activities data on record, last reported at $10.4 million in Q3 2023.

  • For Q3 2023, Cash from Investing Activities changed N/A year-over-year to $10.4 million; the TTM value through Dec 2024 reached $10.4 million, changed 0.0%, while the annual FY2023 figure was $10.4 million, N/A changed from the prior year.
  • Cash from Investing Activities reached $10.4 million in Q3 2023 per CYCN's latest filing, up from -$7000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $10.4 million in Q3 2023 and bottomed at -$4.2 million in Q2 2019.
  • Average Cash from Investing Activities over 4 years is $430166.7, with a median of -$36000.0 recorded in 2020.
  • Peak YoY movement for Cash from Investing Activities: soared 1536.0% in 2020, then plummeted 333.33% in 2021.
  • A 4-year view of Cash from Investing Activities shows it stood at -$100000.0 in 2019, then skyrocketed by 1536.0% to $1.4 million in 2020, then crashed by 100.49% to -$7000.0 in 2021, then soared by 148700.0% to $10.4 million in 2023.
  • Per Business Quant database, its latest 3 readings for Cash from Investing Activities were $10.4 million in Q3 2023, -$7000.0 in Q3 2021, and $2000.0 in Q2 2021.